Increased cerebral activity in Parkinson's disease patients carrying the DRD2 TaqIA A1 allele during a demanding motor task: A compensatory mechanism?

Genes, Brain and Behavior

Volumn 6, Issue 6, 2007, Pages 588-592

  Bartres Faz D ^a   Marti M J ^a,b   Junque C ^a   Sole Padulles C ^a   Ezquerra, M ^b   Bralten, L B C ^a   Gaig, C ^b   Campdelacreu, J ^b   Mercader, J Ma ^b   Tolosa, E ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Dopamine; Functional magnetic resonance; Genetics; Motor function; Parkinson disease

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CEREBELLUM CORTEX; CLINICAL ARTICLE; DEMOGRAPHY; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC VARIABILITY; HUMAN; MALE; MOTOR PERFORMANCE; PARKINSON DISEASE; PREMOTOR CORTEX; PRIORITY JOURNAL;

ADAPTATION, PHYSIOLOGICAL; AGED; AROUSAL; ATTENTION; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR SKILLS; NEURAL PATHWAYS; PARKINSON DISEASE; RECEPTORS, DOPAMINE D2;

EID: 34547830841     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2006.00290.x     Document Type: Article

References (29)

1. Baik, J.H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M. Borrelli, E 1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424 428.
2. Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A.R., Bioulac, B., Brotchie, J.M. Gross, C.E 2001) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- lesioned macaque model of Parkinson's disease. J Neurosci 21, 6853 6861.
3. Bezard, E., Gross, C.E. Brotchie, M 2003) Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. TINS 26, 215 221.
4. Bondi, M.W., Houston, W.S., Eyler, L.T. Brown, G.G 2005) fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64, 501 508.
5. Bookheimer, S.Y., Strojwas, M.H., Cohen, M.S., Saunders, A.M., Perikac-Vance, M.A., Mazziotta, J.C. Small, G.W 2000) Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343, 450 456.
6. Brandstaedter, D., Spieker, S., Ulm, G., Siebert, U., Eichhorn, T.E., Krig, J.C., Oertel, W.H. Eggert, K 2005) Development and evaluation of the Parkinson Psychosis Questionnaire. J Neurol 252, 1060 1066.
7. Buhmann, C., Binkofski, F., Klein, C., Büchel, C., van Eimeren, T., Erdmann, C., Hedrich, K., Kasten, M., Hagenah, J., Deuschl, G., Pramstaller, P.P. Siebner, H.R 2005) Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism. Brain 128, 2281 2290.
8. Catalan, M.J., Ishii, K., Honda, M., Samii, A. Hallett, M 1999) A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 122, 483 495.
9. Daniel, S.E. Lees, A.J 1993) Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39, 165 172.
10. Egan, M.F., Goldberg, T.E., Kolachana, B.S., Callicot, J.H., Mazzanti, C.M., Straub, R.E., Goldman, D. Weinberger, D.R 2001) Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. PNAS 98, 6917 6922.
11. Egan, M.F., Kokima, M., Callicot, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B. Weinberger, D.R 2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. PNAS 112, 257 269.
12. Folstein, M.F., Folstein, S.E. McHugh, P.R 1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189 198.
13. Gosal, D., Ross, O.A. Toft, M 2006) Parkinson's disease: the genetics of a heterogeneous disorder. Eur J Neurol 13, 616 627.
14. Grandy, D., Litt, M., Allen, L., Bunzow, J.R., Marchionni, M., Makam, H., Reed, L., Magenis, R.E. Civelli, O 1989) The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45, 778 785.
15. Grevle, L., Güzey, C., Hadidi, H., Brennersted, R., Idle, J.R. Aasly, J 2000) Allelic association between the DRD2 TaqI polymorphism and Parkinson's disease. Mov Disord 15, 1070 1074.
16. Jankovic, J., McDermott, M., Carter, J., Gauthier, S., Goetz, C., Golbe, L., Huber, S., Koller, W., Olanow, C., Shoulson, I., Stern, M., Tanner, C., Weiner, W the Parkinson Study Group (1990) Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology 40, 1529 1534.
17. Khan, N.L., Valente, E.M., Bentivoglio, A.R., Wood, N.W., Albanese, A., Brooks, D.J. Piccini, P 2002). Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study. Ann Neurol 52, 849 853.
18. Makoff, A.J., Graham, J.M., Arranz, M.J., Forsyth, J., Li, T., Aitchison, K.J., Shaikh, S. Grünewald, R.A 2000) Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease Pharmacogenetics 10, 43 48.
19. Noble, E.P 2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet 116B, 103 125.
20. Obeso, J., Rodriguez-Oroz, M.C., Lanciego, J.L. Rodriguez Diaz, M 2004) How does Parkinson's disease begin? The role of compensatory mechanisms TINS 27, 125 127.
21. Oliveri, R.L., Annesi, G., Zappia, M., Civitelli, D., De Marco, E.V., Pasqua, A.A., Annesi, F., Spadafora, P., Gambardella, A., Nicoletti, G., Branca, D., Caracciolo, M., Aguglia, U. Quattrone, A 2000) The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease. Mov Disord 15, 127 131.
22. Paus, S., Seeger, G., Brecht, H.M., Köster, J., El-Faddagh, M., Nöthen, M.M., Klockgether, T. Wüllner, U 2004) Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease. Mov Disord 19, 705 707.
23. Rissling, I., Geller, F., Bandmann, O., Stiasny-Kolster, K., Körner, Y., Meindorfner, C., Krüger, H.-P., Oertel, W.H. Möller, J.C 2004) Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting 'sleep attacks'. Mov Disord 19, 1279 1284.
24. Sabatini, U., Boulanouar, K., Fabre, N., Martin, F., Carel, C., Colonnese, C., Bozzao, L., Berry, I., Montastruc, J.L., Chollet, F. Rascol, O 2000) Cortical motor reorganization in akinetic patients with Parkinson's disease. A functional MRI study. Brain 123, 394 403.
25. Samuel, M., Ceballos-Bauman, A.O., Blin, J., Uema, T., Boecker, H., Passingham, R.E. Brooks, D.J 1997) Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements. A PET study. Brain 120, 963 976.
26. Smits, S.M., Mathon, D.S., Burbach, J.P.H., Ramakers, G.M.J. Smidt, M.P 2005) Molecular and cellular alterations in the Pitx-3-deficient midbrain dopaminergic system. Mol Cell Neurosci 30, 352 363.
27. Tan, E.K., Tan, Y., Chai, A., Tan, C., Shen, H., Lum, S-Y., Fook-Cheong, S.M.C., Teoh, M-L., Yih, Y., Wong, M-C. Zhao, Y 2003) Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease. Mov Disord 18, 593 601.
28. Wang, J., Liu, Z.L. Chen, B 2001) Association study of dopamine D2, D3 receptor gene polymorphisms with motor fluctuations in PD. Neurology 56, 1717 1759.
29. Wu, T. Hallett, M 2005) A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 128, 2250 2259.